UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $251,000 | -76.0% | 13,377 | -73.5% | 0.02% | -61.5% |
| Q4 2021 | $1,046,000 | -52.6% | 50,412 | -26.8% | 0.04% | -65.8% |
| Q3 2021 | $2,206,000 | +455.7% | 68,902 | +526.4% | 0.11% | +245.5% |
| Q4 2020 | $397,000 | -20.0% | 11,000 | 0.0% | 0.03% | -59.8% |
| Q2 2020 | $496,000 | +21.6% | 11,000 | +27.9% | 0.08% | +67.3% |
| Q1 2020 | $408,000 | +20.7% | 8,600 | 0.0% | 0.05% | +133.3% |
| Q3 2019 | $338,000 | – | 8,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |